Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

Roche, Boehringer tap biosensor firms for patient studies

A new dawn of the genomic age: five areas set to be transformed in 2023

ABPI code updated with first social media guidance

NICE recommends first CAR-T cell therapy on NHS in England

EU clears Enhertu for HER2-low breast cancer

home care

Steady_Health_glucose_device

Digital/ News/ News

Carbon Health buys virtual diabetes clinic firm Steady Health

Phil Taylor Carbon Health, continuous glucose monitoring, Diabetes, digital, digital health, endocrinology, home care, Steady Health 0 Comment

US healthcare group Carbon Health has made a move into digital care for patients with chronic conditions, buying

X

Carbon Health buys virtual diabetes clinic firm Steady Health

https://pharmaphorum.com/news/carbon-health-buys-virtual-diabetes-clinic-firm-steady-health/

The home advantage 570x320

Articles/ Cancer/ Healthcare/ Views and analysis

The home advantage in cancer care

Linda Banks cancer, cancer care, cancer care pathway, cancer management, home care, Oncology, patient centricity 0 Comment

The optimal cancer care pathway for this complex disease outside the hospital.

X

The home advantage in cancer care

https://pharmaphorum.com/views-and-analysis/cancer-care-at-home/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

Frontiers Health Steering Committee spotlight – Monique Levy

Frontiers Health Steering Committee spotlight – Monique Levy

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Most popular

Most Viewed

ALS drug tofersen will face FDA advisors, says Biogen
Amazon unveils $5 subscription service for generics
NICE recommends first CAR-T cell therapy on NHS in England
Lilly injects $450m into plant making Mounjaro
ABPI code updated with first social media guidance

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2023

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com